A start-up is offering psychedelic-assisted mental wellness therapies. NUE Life Health, currently operating in California, Texas and Florida, is developing a digital platform that will offer at-home ketamine therapy.
Studies are finding increasing evidence that psychedelics like LSD and psilocybin (active ingredient in shrooms) and mind-altering drugs like ketamine or MDMA, when combined with psychotherapy, is showing real promise in addressing mental health disorders like depression and anxiety.
It's not clear how the drugs work, though one theory is they help encourage the development of neuroplasticity in the severely depressed or anxious brain.
How it works? Wearable devices help "digital phenotyping" on data points like sleep and activity that produce patient information that goes beyond the self-reporting generally used to guide mental health therapy. NUE will assess patients when they start to get their baseline statistics. Then after each experience, assess them again to see how well they're doing and tweak further treatment as needed.
Short Squeez Takeaway: The potential misuse of drugs like ketamine and MDMA means psychedelic treatments will always face pushback from the pious amongst us. Psychedelic therapy is still in its early days but looks to be entering a boomin' phase with more interest and funding from both the private sector and federal governments.